Correlation Between Sinphar Pharmaceutical and Icares Medicus
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Icares Medicus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Icares Medicus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Icares Medicus, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Icares Medicus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Icares Medicus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Icares Medicus.
Diversification Opportunities for Sinphar Pharmaceutical and Icares Medicus
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sinphar and Icares is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Icares Medicus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icares Medicus and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Icares Medicus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icares Medicus has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Icares Medicus go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and Icares Medicus
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.71 times more return on investment than Icares Medicus. However, Sinphar Pharmaceutical Co is 1.4 times less risky than Icares Medicus. It trades about 0.23 of its potential returns per unit of risk. Icares Medicus is currently generating about -0.1 per unit of risk. If you would invest 2,930 in Sinphar Pharmaceutical Co on October 24, 2024 and sell it today you would earn a total of 145.00 from holding Sinphar Pharmaceutical Co or generate 4.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sinphar Pharmaceutical Co vs. Icares Medicus
Performance |
| Timeline |
| Sinphar Pharmaceutical |
| Icares Medicus |
Sinphar Pharmaceutical and Icares Medicus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sinphar Pharmaceutical and Icares Medicus
The main advantage of trading using opposite Sinphar Pharmaceutical and Icares Medicus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Icares Medicus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icares Medicus will offset losses from the drop in Icares Medicus' long position.| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
| Icares Medicus vs. Pegavision | Icares Medicus vs. StShine Optical Co | Icares Medicus vs. Bioteque | Icares Medicus vs. Medeon Biodesign |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |